Alignment Healthcare (ALHC) Fundamental Analysis: Revenue, Earnings & Valuation

8.62 / 10

Outperform

Fundamental analysis rates ALHC as Outperform with an 8.6/10 score. Key strengths are robust YoY profit growth, high revenue‑to‑market‑value and strong cash‑flow metrics. Weak points include low asset‑to‑market‑value and declining cash‑up, but overall the fundamentals are highly favorable.

Analysis Checks(6/10)

Revenue-MV

Value0.83

Score2/3

Weight21.61%

1M Return3.24%

Net cash flow from operating activities per share (YoY growth rate %)

Value278.04

Score3/3

Weight37.79%

1M Return5.35%

PB-ROE

Value2.49

Score0/3

Weight-5.96%

1M Return-1.30%

Basic earnings per share (YoY growth rate %)

Value100.00

Score2/3

Weight10.05%

1M Return1.70%

Total profit (YoY growth rate %)

Value99.25

Score2/3

Weight11.76%

1M Return1.87%

Net cash flow from operating activities (YoY growth rate %)

Value302.44

Score3/3

Weight38.52%

1M Return5.57%

Cash-UP

Value-0.15

Score0/3

Weight-24.08%

1M Return-4.87%

Diluted earnings per share (YoY growth rate %)

Value100.00

Score2/3

Weight7.35%

1M Return1.25%

Asset-MV

Value-0.55

Score0/3

Weight-5.25%

1M Return-0.96%

Cash-MV

Value0.02

Score1/3

Weight8.20%

1M Return1.42%

Is ALHC fundamentally strong?

ALHC scores 8.62/10 on fundamentals and holds a Discounted valuation at present. Backed by its -0.52% ROE, -0.02% net margin, -5073.55 P/E ratio, 20.49 P/B ratio, and 100.00% earnings growth, these metrics solidify its Outperform investment rating.